- call +1-201-465-4211
- email sales@mrinsights.biz
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis.
Scope of the Report:
This report focuses on the Etanercept in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The production of TNF in the body causes inflammation, pain, and damage to the bones and joints. Etanercept blocks the action of TNF and reduces the inflammation. It is prescribed to treat juvenile rheumatoid arthritis, rheumatoid arthritis, and psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis.
The worldwide market for Etanercept is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Takeda
Johnson & Johnson
GlaxoSmithKline
Samsung Bioepis
Roche
Cipla
Novartis
Celltrion
Immunex
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Benepali
Enbrel
Others
Market Segment by Applications, can be divided into
Arthritis
Psoriasis
Spondylitis
There are 15 Chapters to deeply display the global Etanercept market.
Chapter 1, to describe Etanercept Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Etanercept, with sales, revenue, and price of Etanercept, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Etanercept, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Etanercept market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Etanercept sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Etanercept Introduction
1.2 Market Analysis by Type
1.2.1 Benepali
1.2.2 Enbrel
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Arthritis
1.3.2 Psoriasis
1.3.3 Spondylitis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Etanercept Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Takeda
2.2.1 Business Overview
2.2.2 Etanercept Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Takeda Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Etanercept Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
2.4.1 Business Overview
2.4.2 Etanercept Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GlaxoSmithKline Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Samsung Bioepis
2.5.1 Business Overview
2.5.2 Etanercept Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Samsung Bioepis Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Etanercept Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cipla
2.7.1 Business Overview
2.7.2 Etanercept Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cipla Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Etanercept Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Celltrion
2.9.1 Business Overview
2.9.2 Etanercept Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Celltrion Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Immunex
2.10.1 Business Overview
2.10.2 Etanercept Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Immunex Etanercept Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Etanercept Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Etanercept Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Etanercept Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Etanercept Manufacturer Market Share in 2017
3.3.2 Top 6 Etanercept Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Etanercept Market Analysis by Regions
4.1 Global Etanercept Sales, Revenue and Market Share by Regions
4.1.1 Global Etanercept Sales and Market Share by Regions (2013-2018)
4.1.2 Global Etanercept Revenue and Market Share by Regions (2013-2018)
4.2 North America Etanercept Sales and Growth Rate (2013-2018)
4.3 Europe Etanercept Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Etanercept Sales and Growth Rate (2013-2018)
4.5 South America Etanercept Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Etanercept Sales and Growth Rate (2013-2018)
5 North America Etanercept by Countries
5.1 North America Etanercept Sales, Revenue and Market Share by Countries
5.1.1 North America Etanercept Sales and Market Share by Countries (2013-2018)
5.1.2 North America Etanercept Revenue and Market Share by Countries (2013-2018)
5.2 United States Etanercept Sales and Growth Rate (2013-2018)
5.3 Canada Etanercept Sales and Growth Rate (2013-2018)
5.4 Mexico Etanercept Sales and Growth Rate (2013-2018)
6 Europe Etanercept by Countries
6.1 Europe Etanercept Sales, Revenue and Market Share by Countries
6.1.1 Europe Etanercept Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Etanercept Revenue and Market Share by Countries (2013-2018)
6.2 Germany Etanercept Sales and Growth Rate (2013-2018)
6.3 UK Etanercept Sales and Growth Rate (2013-2018)
6.4 France Etanercept Sales and Growth Rate (2013-2018)
6.5 Russia Etanercept Sales and Growth Rate (2013-2018)
6.6 Italy Etanercept Sales and Growth Rate (2013-2018)
7 Asia-Pacific Etanercept by Countries
7.1 Asia-Pacific Etanercept Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Etanercept Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Etanercept Revenue and Market Share by Countries (2013-2018)
7.2 China Etanercept Sales and Growth Rate (2013-2018)
7.3 Japan Etanercept Sales and Growth Rate (2013-2018)
7.4 Korea Etanercept Sales and Growth Rate (2013-2018)
7.5 India Etanercept Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Etanercept Sales and Growth Rate (2013-2018)
8 South America Etanercept by Countries
8.1 South America Etanercept Sales, Revenue and Market Share by Countries
8.1.1 South America Etanercept Sales and Market Share by Countries (2013-2018)
8.1.2 South America Etanercept Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Etanercept Sales and Growth Rate (2013-2018)
8.3 Argentina Etanercept Sales and Growth Rate (2013-2018)
8.4 Colombia Etanercept Sales and Growth Rate (2013-2018)
9 Middle East and Africa Etanercept by Countries
9.1 Middle East and Africa Etanercept Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Etanercept Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Etanercept Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Etanercept Sales and Growth Rate (2013-2018)
9.3 UAE Etanercept Sales and Growth Rate (2013-2018)
9.4 Egypt Etanercept Sales and Growth Rate (2013-2018)
9.5 Nigeria Etanercept Sales and Growth Rate (2013-2018)
9.6 South Africa Etanercept Sales and Growth Rate (2013-2018)
10 Global Etanercept Market Segment by Type
10.1 Global Etanercept Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Etanercept Sales and Market Share by Type (2013-2018)
10.1.2 Global Etanercept Revenue and Market Share by Type (2013-2018)
10.2 Benepali Sales Growth and Price
10.2.1 Global Benepali Sales Growth (2013-2018)
10.2.2 Global Benepali Price (2013-2018)
10.3 Enbrel Sales Growth and Price
10.3.1 Global Enbrel Sales Growth (2013-2018)
10.3.2 Global Enbrel Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global Etanercept Market Segment by Application
11.1 Global Etanercept Sales Market Share by Application (2013-2018)
11.2 Arthritis Sales Growth (2013-2018)
11.3 Psoriasis Sales Growth (2013-2018)
11.4 Spondylitis Sales Growth (2013-2018)
12 Etanercept Market Forecast (2018-2023)
12.1 Global Etanercept Sales, Revenue and Growth Rate (2018-2023)
12.2 Etanercept Market Forecast by Regions (2018-2023)
12.2.1 North America Etanercept Market Forecast (2018-2023)
12.2.2 Europe Etanercept Market Forecast (2018-2023)
12.2.3 Asia-Pacific Etanercept Market Forecast (2018-2023)
12.2.4 South America Etanercept Market Forecast (2018-2023)
12.2.5 Middle East and Africa Etanercept Market Forecast (2018-2023)
12.3 Etanercept Market Forecast by Type (2018-2023)
12.3.1 Global Etanercept Sales Forecast by Type (2018-2023)
12.3.2 Global Etanercept Market Share Forecast by Type (2018-2023)
12.4 Etanercept Market Forecast by Application (2018-2023)
12.4.1 Global Etanercept Sales Forecast by Application (2018-2023)
12.4.2 Global Etanercept Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Etanercept Picture
Table Product Specifications of Etanercept
Figure Global Sales Market Share of Etanercept by Types in 2017
Table Etanercept Types for
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
